7vgy
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[7vgy]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus], [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens], [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7VGY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7VGY FirstGlance]. <br> | <table><tr><td colspan='2'>[[7vgy]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus], [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens], [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7VGY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7VGY FirstGlance]. <br> | ||
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ML2:N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE'>ML2</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.1Å</td></tr> |
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ML2:N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE'>ML2</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7vgy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7vgy OCA], [https://pdbe.org/7vgy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7vgy RCSB], [https://www.ebi.ac.uk/pdbsum/7vgy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7vgy ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7vgy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7vgy OCA], [https://pdbe.org/7vgy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7vgy RCSB], [https://www.ebi.ac.uk/pdbsum/7vgy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7vgy ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/GBG2_BOVIN GBG2_BOVIN] Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| - | Melatonin receptors ( | + | Melatonin receptors (MT(1) and MT(2) in humans) are family A G protein-coupled receptors that respond to the neurohormone melatonin to regulate circadian rhythm and sleep. Numerous efforts have been made to develop drugs targeting melatonin receptors for the treatment of insomnia, circadian rhythm disorder, and cancer. However, designing subtype-selective melatonergic drugs remains challenging. Here, we report the cryo-EM structures of the MT(1)-G(i) signaling complex with 2-iodomelatonin and ramelteon and the MT(2)-G(i) signaling complex with ramelteon. These structures, together with the reported functional data, reveal that although MT(1) and MT(2) possess highly similar orthosteric ligand-binding pockets, they also display distinctive features that could be targeted to design subtype-selective drugs. The unique structural motifs in MT(1) and MT(2) mediate structural rearrangements with a particularly wide opening on the cytoplasmic side. G(i) is engaged in the receptor core shared by MT(1) and MT(2) and presents a conformation deviating from those in other G(i) complexes. Together, our results provide new clues for designing melatonergic drugs and further insights into understanding the G protein coupling mechanism. |
Structural basis of the ligand binding and signaling mechanism of melatonin receptors.,Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, Du Y, Liu Z, Tao Y Nat Commun. 2022 Jan 24;13(1):454. doi: 10.1038/s41467-022-28111-3. PMID:35075127<ref>PMID:35075127</ref> | Structural basis of the ligand binding and signaling mechanism of melatonin receptors.,Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, Du Y, Liu Z, Tao Y Nat Commun. 2022 Jan 24;13(1):454. doi: 10.1038/s41467-022-28111-3. PMID:35075127<ref>PMID:35075127</ref> | ||
Current revision
Melatonin receptor1-2-Iodomelatonin-Gicomplex
| |||||||||||
